NCT06830538 Study of the Anatomical and Functional Recovery and Quality of Life of Patients Undergoing Corneal Transplantation
| NCT ID | NCT06830538 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Cornea Transplant |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-11-11 |
| Primary Completion | 2035-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-11-11 with a primary completion date of 2035-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluate the well-being of patients and clinicl outcomes of the cornea after transplantation
Eligibility Criteria
Inclusion Criteria: * be eighteen years old * diagnosis of corneal disease with prescription of surgical treatment of corneal transplantation * sign the informed consent Exclusion Criteria: * no exclusion criteria
Contact & Investigator
Luigi Fontana, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06830538 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cornea Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06830538 currently recruiting?
Yes, NCT06830538 is actively recruiting participants. Contact the research team at luigi.fontana6@unibo.it for enrollment information.
Where is the NCT06830538 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06830538 clinical trial?
NCT06830538 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Luigi Fontana, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 2,000 participants.